National NAIDOC Week celebrations are held across Australia in the first week of July each year (Sunday to Sunday), to celebrate and recognise the history, culture and achievements of Aboriginal and Torres Strait Islander peoples.
On the eve of NAIDOC week 2023, Australian Health Journal met with Scott Willis, the National President of the Australian Physiotherapy Association, a proud Palawa man and the first Indigenous President of the Australian health peak body.
Growing in up the western suburbs of Sydney and attending local public schools, hard work and committing fully to the task at hand was instilled in Scott from a young age. In 1993, he graduated from the University of Sydney with a Bachelor of Applied Science (Physiotherapy).
Freshly graduated, he moved to the North West Coast of Tasmania to reconnect with his Aboriginal roots on his father’s side and start his career. Joining the APA led to the first of several voluntary leadership roles within the organisation, from National Chair of the business group, member of the National Advisory Committee, Tasmanian branch councillor, Board Director and Chair of the Insurance and Safety subcommittee.
Today he is co-director of a multidisciplinary clinic in Tasmania. Within the Tasmanian health system, Scott has held positions on the Board of Directors of the Division of General Practice North West in Tasmania, Tasmania’s Medicare Local’s Primary Health Care Strategic Advisory Council, and the Clinical Advisory Council of Primary Health Tasmania.
When elected to the position in 2020, Scott stated he would be unapologetically ambitious given his extensive experience in policy development, advocacy and political engagement.
He said, “As a profession we’ve come a long way to illustrate how valuable our work is, both from a broad health system cost perspective and as highly skilled clinicians treating a wide array of acute and chronic health conditions.”
“One of our key focus areas will be illustrating the economic value of physio and partnering with government and insurers to ensure the best and most effective health outcomes for Australians.”
“Aboriginal and Torres Strait Islander peoples’ health remains a priority area for our profession. We’re going to ensure not only that we are a culturally safe, engaged profession by listening to, learning from and working with First Nations peoples, but we’re going to make physio a known, viable and aspirational professional choice for young Aboriginals coming through the education system. I want them to know they can and should aspire to strong and respected leadership roles in the community.”
His passion for the profession and the organisation help drive it forward and continue to put it at the forefront of politicians’, funders’ and consumers’ minds.
In an upcoming release Part 2 of the interview with Scott Willis, he discusses the growth of the profession within allied health, role in society, research and education.
You Might also like
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia
-
Dr Anjali Jaiprakash, Robobiologist from Queensland University of Technology
Dr Anjali Jaiprakash is a robobiologist working at the intersection of medicine, engineering and design, with a transdisciplinary approach to develop medical devices that translate robotic vision into affordable systems that can be used to improve healthcare outcomes. Anjali has experience in the fields of medical robotics, medical device, orthopaedics, trauma, bone and cartilage biology. She spoke with Anne Dao following her talk “The Robot Doctor Will See you Now” at Australian Healthcare Week 2019.
Post Views:
1,446 -
Improved access to technology needed for people with Type 2 Diabetes needing insulin
The National Diabetes Services Scheme (NDSS) provides subsidised products for diabetes management; however, disparities exist in access to technology between those with Type 1 and Type 2 diabetes. While continuous glucose monitoring (CGM) devices are subsidised for Type 1, they are not available for Type 2 diabetes. ADEA advocates for equitable access to these essential tools, emphasising that all individuals with diabetes deserve the resources necessary for optimal management and reduced risk of complications. Without such technologies, many are forced to rely on finger pricking, which can be inconvenient and unsafe in settings such as the workplace and in higher education.